NASDAQ:NXGN - Nextgen Healthcare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $18.56 -0.19 (-1.01 %) (As of 02/19/2019 04:00 PM ET)Previous Close$18.75Today's Range$18.50 - $18.9052-Week Range$12.24 - $23.73Volume165,874 shsAverage Volume310,769 shsMarket Capitalization$1.20 billionP/E Ratio32.56Dividend YieldN/ABeta1.11 ProfileDiscussionAnalyst RatingsChartEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email NextGen Healthcare, Inc. provides software, services, and analytics solutions to medical and dental group practices in the United States. The company's principal products include NextGen Enterprise EHR, which stores and maintains clinical patient information; and a workflow module, prescription management, automatic document and letter generation, patient education, referral tracking, interfaces to billing and lab systems, physician alerts and reminders, and reporting and data analysis tools. Its products also comprise NextGen Enterprise PM, a practice management (PM) solution; and NextGen Office, a cloud-based electronic health record and PM solution. In addition, the company offers automation and workflow solutions, including NextGen Mobile Health Solutions, NextGen Electronic Healthcare Transactions, NextGen Pre-Service Clearance, and NextGen Patient Payment solutions. Further, it provides analytics, population health, and patient engagement solutions, such as NextGen Population Health Informed Analytics, NextGen Population Health Patient Care Coordination, NextGen Population Health Performance Management, and NextGen Patient Portal solutions. Additionally, the company offers NextGen Connected Health and NextGen Share interoperability solutions. It also provides professional services, including training, project management, functional and detailed specification preparation, configuration, testing, installation, support, and client services. It serves physician hospital and management service organizations, independent physician associations, accountable care organizations, ambulatory care centers, and community health centers through a sales force and reseller channel. NextGen Healthcare, Inc. has a strategic partnership with OTTO Health LLC. The company was formerly known as Quality Systems, Inc. and changed its name to NextGen Healthcare, Inc. in September 2018. NextGen Healthcare, Inc. was founded in 1974 and is headquartered in Irvine, California. Receive NXGN News and Ratings via Email Sign-up to receive the latest news and ratings for NXGN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Computer integrated systems design Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NXGN Previous Symbol CUSIPN/A Webwww.nextgen.com Phone949-255-2600Debt Debt-to-Equity Ratio0.07 Current Ratio1.32 Quick Ratio1.31Price-To-Earnings Trailing P/E Ratio32.56 Forward P/E Ratio32.56 P/E Growth3.57 Sales & Book Value Annual Sales$531.02 million Price / Sales2.26 Cash Flow$1.3098 per share Price / Cash Flow14.17 Book Value$5.65 per share Price / Book3.28Profitability EPS (Most Recent Fiscal Year)$0.57 Net Income$2.42 million Net Margins1.80% Return on Equity10.66% Return on Assets6.96%Miscellaneous Employees2,830 Outstanding Shares64,697,000Market Cap$1.20 billion OptionableOptionable Nextgen Healthcare (NASDAQ:NXGN) Frequently Asked Questions What is Nextgen Healthcare's stock symbol? Nextgen Healthcare trades on the NASDAQ under the ticker symbol "NXGN." How were Nextgen Healthcare's earnings last quarter? Nextgen Healthcare Inc (NASDAQ:NXGN) issued its quarterly earnings results on Wednesday, January, 23rd. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.11 by $0.01. The business earned $130.87 million during the quarter, compared to the consensus estimate of $130.79 million. Nextgen Healthcare had a return on equity of 10.66% and a net margin of 1.80%. View Nextgen Healthcare's Earnings History. When is Nextgen Healthcare's next earnings date? Nextgen Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, May 23rd 2019. View Earnings Estimates for Nextgen Healthcare. What guidance has Nextgen Healthcare issued on next quarter's earnings? Nextgen Healthcare issued an update on its FY19 earnings guidance on Wednesday, January, 23rd. The company provided EPS guidance of $0.72-0.76 for the period, compared to the Thomson Reuters consensus estimate of $0.72. The company issued revenue guidance of $525-535 million, compared to the consensus revenue estimate of $530.21 million.Nextgen Healthcare also updated its FY 2019 guidance to $0.72-0.76 EPS. What price target have analysts set for NXGN? 4 brokers have issued 12-month price targets for Nextgen Healthcare's shares. Their predictions range from $16.00 to $23.00. On average, they expect Nextgen Healthcare's stock price to reach $18.50 in the next twelve months. This suggests that the stock has a possible downside of 0.3%. View Analyst Price Targets for Nextgen Healthcare. What is the consensus analysts' recommendation for Nextgen Healthcare? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nextgen Healthcare in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Nextgen Healthcare. What are Wall Street analysts saying about Nextgen Healthcare stock? Here are some recent quotes from research analysts about Nextgen Healthcare stock: 1. According to Zacks Investment Research, "NextGen outperformed its industry in a year's time. NextGen currently rides on Software, hardware and other non-recurring unit. Management presently foresees solid growth prospects in the RCM pipeline as well. The NextGen population health analytics suite and NextGen mobile platform registered significant growth. Solid bookings growth deserves mention. For investors’ notice, the company expects high-single digit revenue growth by fiscal 2020. NextGen announced the availability of Quality/Cost Fusion – a new Population Health analytics capability. Quality/Cost Fusion is a part of NextGen Population Health platform – a modular, cloud-based solution. On the positive side, NextGen's lowered guidance for fiscal 2019 indicates looming concerns ahead. Also, the plummeting gross profit is a negative. Sluggishness in the recurring revenue segment in recent times adds to the woes. The company faces stiff rivalry in MedTech space. " (1/7/2019) 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on NXGN shares and maintain our price target of $23. We recently met with NXGN management team. We remain confident that some of the issues that came up with its F2Q19 results (reported in late October) were temporary in nature. As a reminder, F2Q19 bookings were about $36 million, representing growth of 39% y/y, which is impressive. However, as deal size increases, implementation timelines expand and short-term revenue is not hitting expectations. The company also experienced higher-than-expected customer attrition. After considering the elevated attrition during the quarter and the company’s expectation that it will remain elevated for some time, we reduced our F20 revenue growth assumption to 5.7% from 7.0%." (12/6/2018) Has Nextgen Healthcare been receiving favorable news coverage? News coverage about NXGN stock has trended somewhat positive recently, according to InfoTrie. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nextgen Healthcare earned a daily sentiment score of 0.9 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the near term. Are investors shorting Nextgen Healthcare? Nextgen Healthcare saw a drop in short interest during the month of January. As of January 31st, there was short interest totalling 1,265,414 shares, a drop of 39.5% from the January 15th total of 2,091,584 shares. Based on an average daily trading volume, of 336,806 shares, the days-to-cover ratio is currently 3.8 days. Currently, 2.7% of the company's stock are short sold. View Nextgen Healthcare's Current Options Chain. Who are some of Nextgen Healthcare's key competitors? Some companies that are related to Nextgen Healthcare include Caci International (CACI), Verint Systems (VRNT), Science Applications International (SAIC), Scientific Games (SGMS), Allscripts Healthcare Solutions (MDRX), NetScout Systems (NTCT), Ebix (EBIX), Sykes Enterprises (SYKE), Unisys (UIS), Onespan (OSPN), Ribbon Communications (RBBN), Agilysys (AGYS), KEYW (KEYW), Simulations Plus (SLP) and Pareteum (TEUM). Who are Nextgen Healthcare's key executives? Nextgen Healthcare's management team includes the folowing people: Mr. John R. Frantz, Pres, CEO & Director (Age 52)Mr. James Robert Arnold Jr., Exec. VP, CFO & Principal Accounting Officer (Age 63)Mr. David A. Metcalfe, Exec. VP & Chief Technology Officer (Age 56)Mr. Jeffrey D. Linton, Exec. VP, Gen. Counsel & Sec. (Age 56)Mr. Scott E. Bostick, Non-Exec. Officer (Age 54) Who are Nextgen Healthcare's major shareholders? Nextgen Healthcare's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (11.20%), Dimensional Fund Advisors LP (3.73%), New York State Common Retirement Fund (2.36%), Investment Counselors of Maryland LLC (1.96%), Geode Capital Management LLC (1.37%) and Elk Creek Partners LLC (1.33%). Which major investors are selling Nextgen Healthcare stock? NXGN stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Algert Global LLC, Bank of New York Mellon Corp, D. E. Shaw & Co. Inc., Barclays PLC, Connor Clark & Lunn Investment Management Ltd., Virginia Retirement Systems ET AL and Two Sigma Investments LP. Which major investors are buying Nextgen Healthcare stock? NXGN stock was bought by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Elk Creek Partners LLC, Dimensional Fund Advisors LP, Bank of America Corp DE, Northpointe Capital LLC, Geode Capital Management LLC, Rhumbline Advisers and Investment Counselors of Maryland LLC. How do I buy shares of Nextgen Healthcare? Shares of NXGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Nextgen Healthcare's stock price today? One share of NXGN stock can currently be purchased for approximately $18.56. How big of a company is Nextgen Healthcare? Nextgen Healthcare has a market capitalization of $1.20 billion and generates $531.02 million in revenue each year. The company earns $2.42 million in net income (profit) each year or $0.57 on an earnings per share basis. Nextgen Healthcare employs 2,830 workers across the globe. What is Nextgen Healthcare's official website? The official website for Nextgen Healthcare is http://www.nextgen.com. How can I contact Nextgen Healthcare? Nextgen Healthcare's mailing address is 18111 Von Karman Avenue Suite 800, Irvine CA, 92612. The company can be reached via phone at 949-255-2600 or via email at [email protected] MarketBeat Community Rating for Nextgen Healthcare (NASDAQ NXGN)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 40 (Vote Outperform)Underperform Votes: 50 (Vote Underperform)Total Votes: 90MarketBeat's community ratings are surveys of what our community members think about Nextgen Healthcare and other stocks. Vote "Outperform" if you believe NXGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXGN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/19/2019 by MarketBeat.com StaffFeatured Article: Hedge Funds - Risk or Reward?